Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Treib

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 1, 1994
[The value of various transcranial color doppler tests for determining cerebrovascular reserve capacity]M Stoll, J Treib, G Hamann, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)]J Treib, A Haass, G Pindur, et al.
Infection|September 1, 1996
Diagnosis of tick-borne encephalitis: evaluation of sera with borderline titers with the TBE-ELISAG Dobler, J Treib, S T Kiessig, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|November 11, 1998
Prevalence of antibodies to tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in samples from patients with abnormalities in the cerebrospinal fluidJ Treib, R Woessner, M T Grauer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 11, 2002
[Studies on the importance of tick-borne encephalitis in Rhineland-Pfalz]M Pietsch, M Vogt, J Süss, et al.
Infection|September 1, 1996
Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalenceJ Treib, A Haass, S T Kiessig, et al.
Infection|December 21, 2006
Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosisR Woessner, M T Grauer, A Frese, et al.
Arzneimittel-Forschung|January 1, 1997
Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starchJ Treib, A Haass, G Pindur, et al.
Haemostasis|August 5, 1998
No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starchM Stoll, J Treib, J F Schenk, et al.
Arzneimittel-Forschung|November 1, 1996
Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseasesJ Treib, A Haass, G Pindur, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|October 1, 1994
[The value of various transcranial color doppler tests for determining cerebrovascular reserve capacity]M Stoll, J Treib, G Hamann, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)]J Treib, A Haass, G Pindur, et al.
Infection|September 1, 1996
Diagnosis of tick-borne encephalitis: evaluation of sera with borderline titers with the TBE-ELISAG Dobler, J Treib, S T Kiessig, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|November 11, 1998
Prevalence of antibodies to tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in samples from patients with abnormalities in the cerebrospinal fluidJ Treib, R Woessner, M T Grauer, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|October 11, 2002
[Studies on the importance of tick-borne encephalitis in Rhineland-Pfalz]M Pietsch, M Vogt, J Süss, et al.
Infection|September 1, 1996
Tick-borne encephalitis diagnosis in patients with inflammatory changes in the cerebrospinal fluid in a region with very low prevalenceJ Treib, A Haass, S T Kiessig, et al.
Infection|December 21, 2006
Long-term antibiotic treatment with roxithromycin in patients with multiple sclerosisR Woessner, M T Grauer, A Frese, et al.
Arzneimittel-Forschung|January 1, 1997
Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starchJ Treib, A Haass, G Pindur, et al.
Haemostasis|August 5, 1998
No coagulation disorders under high-dose volume therapy with low-molecular-weight hydroxyethyl starchM Stoll, J Treib, J F Schenk, et al.
Arzneimittel-Forschung|November 1, 1996
Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseasesJ Treib, A Haass, G Pindur, et al.
Pageof 7